Skip to Content

3QD (Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg)

Generic Name: dasabuvir/ombitasvir/paritaprevir/ritonavir

Pill with imprint 3QD is Yellow, Capsule-shape and has been identified as Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg. It is supplied by AbbVie Inc..

Viekira XR is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Viekira XR dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3QD

Viekira XR

Generic Name
dasabuvir/ombitasvir/paritaprevir/ritonavir
Imprint
3QD
Strength
dasabuvir 200 mg / ombitasvir 8.33 mg / paritaprevir 50 mg / ritonavir 33.33 mg
Color
Yellow
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
AbbVie Inc.
National Drug Code (NDC)
00074-0063
Inactive Ingredients
copovidone, silicon dioxide, magnesium silicate, titanium dioxide, polyethylene glycol 3350, sorbitan monolaurate, tocophersolan, hypromellose 2208 (15000 mPa.s), magnesium stearate, hypromellose 2910 (6 mPa.s), hypromellose 2910 (15 mPa.s), polyethylene glycol 400, polysorbate 80, ferric oxide yellow, hydroxypropyl cellulose (type l)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "3QD"

More about Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)

Consumer resources

Other brands: Viekira Pak

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.